Eleven patients carried variants in genes commonly associated with CFCS, as follows, BRAF (seven patients), MAP2K1 (one patient), MAP2K2 (two patients), and KRAS (one patient). This evidence concerns the gene MAP2K2 and cardiofaciocutaneous syndrome 1.